Online inquiry

IVTScrip™ mRNA-Human ASB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28693MR)

This product GTTS-WK28693MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASB1 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001040445.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51665
UniProt ID Q9Y576
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28693MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK17837MR IVTScrip™ mRNA-Human alpha-SMA, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA alpha-SMA
GTTS-WK24124MR IVTScrip™ mRNA-Human ARID3B, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARID3B
GTTS-WK21830MR IVTScrip™ mRNA-Human ASUN, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASUN
GTTS-WK21513MR IVTScrip™ mRNA-Human ANKRD27, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD27
GTTS-WK12546MR IVTScrip™ mRNA-Human ADGRL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRL2
GTTS-WK15206MR IVTScrip™ mRNA-Human ANKRD2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD2
GTTS-WK15920MR IVTScrip™ mRNA-Human AHCYL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AHCYL1
GTTS-WK14911MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD26P1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW